Adverse events from the Romanian Registry of Rheumatic Diseases in patients treated with biologic and targeted synthetic disease-modifying anti-rheumatic drugs during 2019
Background. The novel therapies in inflammatory rheumatic diseases have changed dramatically the evolution of these conditions, improving patient outcomes, as well as the quality of life. Nevertheless, the efficacy data continuously needs safety reports, on short and long term. Aim. The present stud...
Spremljeno u:
| Glavni autori: | , , |
|---|---|
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
Amaltea Medical Publishing House
2020-03-01
|
| Serija: | Romanian Journal of Rheumatology |
| Teme: | |
| Online pristup: | https://rjr.com.ro/articles/2020.1/RJR_2020_1_Art-03.pdf |
| Oznake: |
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|